Ampleeonsp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2020-07-14
Share capital
5,000.00 PLN
Registered address
ul. Piękna 24/26a, 00-549 Warszawa, Poland
Financials
Revenue history
Financial insight
- The statement flags a going concern risk. Walne Zgromadzenie Wspólników uchwałą z dnia 19 listopada 2025 postawiło Spółkę w stan likwidacji.
From the notes
| Profit allocation | No decision | |
| Merger or transformation | Yes |
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 110 days for 2021).
- 202517/03/2026
- 202414/04/2025
- 202316/07/2024
- 202215/07/2023
- 202102/11/2022
- 202016/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Sławomir Łukasz Kościakage 42 – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sławomir Łukasz Kościakage 42 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2025-05-01 to 2026-03-10.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 1, 2025 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-03 | Name change (Ampleeon → Ampleeon Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2025-11-19 | Liquidation opened | |
| 2023-03-23 | Address change (Ul. Żwirki I Wigury 101, 02-089, Warszawa → Ul. Piękna 24/26a, 00-549, Warszawa) | |
| 2023-03-23 | Name change (Oncoboost → Ampleeon) | |
| 2023-03-23 | PKD change (Removed: 85.60.Z) |
FAQ
The main business activity of Ampleeon focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 14, 2020.
The headquarters is located at: ul. Piękna 24, 00-549 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-10-07